Long QT syndrome caused by noncardiac drugs
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 45 (5), 415-427
- https://doi.org/10.1053/pcad.2003.00101
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general populationJournal of Medical Screening, 2001
- The long QT syndromes: genetic basis and clinical implicationsJournal of the American College of Cardiology, 2000
- QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.European Journal of Clinical Pharmacology, 2000
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- The Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT SyndromeNew England Journal of Medicine, 1992
- The long QT syndromes: A critical review, new clinical observations and a unifying hypothesisProgress in Cardiovascular Diseases, 1988
- Thioridazine (Mellaril®)-induced Ventricular Tachycardia Controlled with an Artificial PacemakerAnnals of Internal Medicine, 1966
- Quinidine SyncopeCirculation, 1964
- Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden deathAmerican Heart Journal, 1957